Remove Compliance Remove Safety Remove Seed-To-Sale Remove Treatment
article thumbnail

The Economic Impact of the Medical Marijuana Industry: Trends and Projections

MMJ Recs

This burgeoning industry encompasses a wide range of activities, including cultivation, processing, distribution, and retail sales of medical cannabis products. The establishment of cultivation, processing, and dispensary facilities creates a diverse array of employment opportunities, spanning from agricultural roles to retail positions.

article thumbnail

Update: Massachusetts Marijuana Establishments Surpass $2 Billion in Gross Sales

Cannabis Law Report

On eve of Commission’s fourth birthday, Marijuana Establishments surpass $2 billion in gross sales since retail stores opened in Massachusetts; progress continues to achieve industry goals. Over the first year of adult-use sales , from November 2018 to November 2019, 33 Marijuana Retailers generated $393.7

Marijuana 100
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cannabis and the LawFoley Hoag LLP Commission Announces New Steps Forward to Advance Cannabis Research in the Commonwealth

Cannabis Law Report

Licensed Research Facilities are also subject to similar requirements as other Marijuana Establishments, such as: registering individuals engaged in research as Marijuana Establishment Agents, compliance with transportation regulations for Marijuana Establishments (935 CMR 500.105(13), and tracking cannabis in the Commission’s seed-to-sale system.

article thumbnail

Cannabis laws in Uruguay

The Cannigma

The government has established a regulated market for the production, sale, and consumption of cannabis. Enforcement of cannabis laws in Uruguay focuses primarily on ensuring compliance with regulations and preventing diversion to the illicit market. The plant has been used for traditional and medicinal purposes for centuries.

Law 52
article thumbnail

You Ask, We Answer (Part 1): Questions From the California Cannabis Webinar

Canna Law Blog

The FDA will treat products as drugs if the labeling or marketing of those products suggests they are “intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease.” The FTC has issued warning letters to companies that advertise their CBD-infused products as treatments or cures for serious medical conditions.

article thumbnail

Cannabis Administration And Opportunity Act: What The Proposed Federal Cannabis Laws Would Mean For Hemp

Cannabis Law Report

The FDA is currently in an ongoing process evaluating the science and safety of CBD and hemp derivatives in order to determine potential regulatory pathways for hemp. While unlikely to pass in this Congress, the momentous legislation gives us a roadmap for how the U.S. Industry stakeholders have until September 1, 2021 to provide feedback.

Hemp 105
article thumbnail

Weekly Legislative Roundup 2/22

NORML

New Jersey lawmakers have come to an agreement with Governor Murphy regarding retail marijuana tax rates, settling on charging sales tax by weight as opposed to a specific percentage. Update : HB 2149 was approved by the Public Safety Committee on 2/20. Welcome to the latest edition of NORML’s Weekly Legislative Roundup!